Share Price and Basic Stock Data
Last Updated: January 21, 2026, 3:29 pm
| PEG Ratio | 0.54 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Continental Chemicals Ltd operates within the IT Consulting and Software industry, with a current share price of ₹79.0 and a market capitalization of ₹17.8 Cr. The company has seen fluctuating sales over the recent quarters, with reported sales of ₹0.12 Cr in September 2022, rising to ₹0.21 Cr in June 2023, before declining to ₹0.05 Cr in September 2023. The trailing twelve months (TTM) sales stood at ₹0.24 Cr, indicating a downward trend from the ₹0.44 Cr reported in March 2023. This inconsistency in revenue generation raises questions about the company’s operational effectiveness and market demand for its services. The operating profit margin (OPM) has been particularly concerning, recorded at -300.00% in September 2023 and showing a negative trend in subsequent quarters. The company’s ability to stabilize its revenue stream will be crucial for its future growth, especially in a competitive IT consulting landscape.
Profitability and Efficiency Metrics
Continental Chemicals Ltd’s profitability metrics highlight significant challenges. The net profit for the company was ₹0.56 Cr, with a return on equity (ROE) of 9.15% and a return on capital employed (ROCE) of 10.7%. However, the negative operating profit margins, which reached an alarming -416.67% in September 2024, indicate that the company is struggling to manage its costs effectively relative to its revenues. The interest coverage ratio (ICR) stood at a solid 15.52x, suggesting that the company can comfortably meet its interest obligations despite its operational losses. The net profit margin also displayed volatility, with a high of 195.95% in March 2025, driven by other income, contrasting sharply with the losses in operating profit. This inconsistency poses a risk to sustainability and investor confidence, as the company must improve its core operations to convert revenues into profits.
Balance Sheet Strength and Financial Ratios
Continental Chemicals Ltd maintains a robust balance sheet, with total borrowings standing at just ₹0.03 Cr, reflecting a low long-term debt-to-equity ratio of 0.01. This positions the company favorably in terms of financial leverage, allowing it to weather downturns without significant debt burdens. Total reserves have increased to ₹3.04 Cr, signaling a build-up of equity capital since March 2024, when it was ₹2.34 Cr. The current ratio is strong at 3.47, indicating that the company can adequately cover its short-term liabilities. However, the price-to-book value (P/BV) ratio of 3.35x suggests that the stock may be overvalued compared to its net assets, which could deter potential investors. Additionally, an enterprise value (EV) of ₹13.92 Cr relative to net operating revenue indicates that the market is pricing the company at a premium despite its operational struggles.
Shareholding Pattern and Investor Confidence
The shareholding structure of Continental Chemicals Ltd reveals a strong promoter presence, with promoters holding 61.57% of the shares consistently over the past quarters. This level of promoter ownership can instill confidence among investors, suggesting a commitment to the company’s long-term success. The public shareholding stood at 38.42%, with a slight fluctuation noted in December 2023, indicating stability in investor sentiment. The number of shareholders has remained relatively constant, with 7,160 shareholders reported in September 2025, reflecting steady interest among retail investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may highlight a lack of institutional confidence, which could impact the stock’s liquidity and overall market perception. The company needs to attract institutional investors to bolster its credibility and support its growth initiatives.
Outlook, Risks, and Final Insight
The outlook for Continental Chemicals Ltd is contingent on its ability to stabilize revenue generation and improve operational efficiency. Key strengths include its low debt levels, which provide financial flexibility, and a solid interest coverage ratio that supports its ability to meet obligations. However, risks remain significant, particularly the continued negative operating profit margins and volatility in net profit, which could deter new investments. Additionally, the company’s reliance on other income to achieve profitability raises concerns about sustainability. Moving forward, Continental Chemicals should focus on enhancing its core business operations and addressing cost management to turn around its performance. If successful, the company could improve its financial metrics and attract institutional investors, but failure to address these operational challenges may hinder future growth prospects.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 60.2 Cr. | 19.0 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 118 Cr. | 109 | 194/99.8 | 18.0 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 45.8 Cr. | 357 | 359/140 | 28.6 | 26.7 | 0.28 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.99 Cr. | 1.11 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,177.70 Cr | 525.37 | 79.39 | 123.68 | 0.60% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.12 | 0.18 | 0.00 | 0.21 | 0.05 | 0.11 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Expenses | 0.21 | 0.20 | 0.24 | 0.22 | 0.20 | 0.24 | 0.19 | 0.23 | 0.31 | 0.27 | 0.18 | 0.21 | 0.24 |
| Operating Profit | -0.09 | -0.02 | -0.24 | -0.01 | -0.15 | -0.13 | -0.14 | -0.18 | -0.25 | -0.21 | -0.12 | -0.15 | -0.18 |
| OPM % | -75.00% | -11.11% | -4.76% | -300.00% | -118.18% | -280.00% | -360.00% | -416.67% | -350.00% | -200.00% | -250.00% | -300.00% | |
| Other Income | 0.20 | 0.21 | 0.24 | 0.19 | 0.29 | 0.34 | 0.32 | 0.33 | 0.30 | 0.38 | 0.34 | 0.35 | 0.35 |
| Interest | 0.00 | 0.00 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.01 | 0.01 | 0.05 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 |
| Profit before tax | 0.10 | 0.18 | -0.08 | 0.15 | 0.12 | 0.18 | 0.15 | 0.12 | 0.02 | 0.14 | 0.19 | 0.16 | 0.14 |
| Tax % | 30.00% | 16.67% | -37.50% | 26.67% | 8.33% | 5.56% | 20.00% | 8.33% | 0.00% | 35.71% | 0.00% | 12.50% | 21.43% |
| Net Profit | 0.07 | 0.15 | -0.05 | 0.11 | 0.12 | 0.18 | 0.12 | 0.11 | 0.03 | 0.10 | 0.20 | 0.14 | 0.12 |
| EPS in Rs | 0.31 | 0.67 | -0.22 | 0.49 | 0.53 | 0.80 | 0.53 | 0.49 | 0.13 | 0.44 | 0.89 | 0.62 | 0.53 |
Last Updated: December 27, 2025, 11:02 am
Below is a detailed analysis of the quarterly data for Continental Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.06 Cr..
- For Expenses, as of Sep 2025, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.21 Cr. (Jun 2025) to 0.24 Cr., marking an increase of 0.03 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from -0.15 Cr. (Jun 2025) to -0.18 Cr., marking a decrease of 0.03 Cr..
- For OPM %, as of Sep 2025, the value is -300.00%. The value appears to be declining and may need further review. It has decreased from -250.00% (Jun 2025) to -300.00%, marking a decrease of 50.00%.
- For Other Income, as of Sep 2025, the value is 0.35 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.35 Cr..
- For Interest, as of Sep 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Jun 2025) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Jun 2025) to 0.14 Cr., marking a decrease of 0.02 Cr..
- For Tax %, as of Sep 2025, the value is 21.43%. The value appears to be increasing, which may not be favorable. It has increased from 12.50% (Jun 2025) to 21.43%, marking an increase of 8.93%.
- For Net Profit, as of Sep 2025, the value is 0.12 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Jun 2025) to 0.12 Cr., marking a decrease of 0.02 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.53. The value appears to be declining and may need further review. It has decreased from 0.62 (Jun 2025) to 0.53, marking a decrease of 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:55 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.58 | 0.43 | 0.49 | 0.60 | 0.61 | 0.19 | 0.31 | 0.19 | 0.48 | 0.44 | 0.42 | 0.22 | 0.24 |
| Expenses | 1.07 | 0.61 | 0.72 | 0.86 | 0.86 | 0.93 | 0.89 | 0.67 | 0.84 | 0.88 | 0.85 | 0.98 | 0.90 |
| Operating Profit | -0.49 | -0.18 | -0.23 | -0.26 | -0.25 | -0.74 | -0.58 | -0.48 | -0.36 | -0.44 | -0.43 | -0.76 | -0.66 |
| OPM % | -84.48% | -41.86% | -46.94% | -43.33% | -40.98% | -389.47% | -187.10% | -252.63% | -75.00% | -100.00% | -102.38% | -345.45% | -275.00% |
| Other Income | 0.62 | 0.46 | 0.46 | 0.39 | 0.38 | 1.12 | 0.88 | 0.77 | 0.56 | 0.83 | 1.15 | 1.35 | 1.42 |
| Interest | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Depreciation | 0.10 | 0.11 | 0.07 | 0.07 | 0.07 | 0.07 | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 | 0.07 | 0.09 |
| Profit before tax | 0.03 | 0.15 | 0.15 | 0.05 | 0.05 | 0.29 | 0.16 | 0.16 | 0.07 | 0.27 | 0.61 | 0.48 | 0.63 |
| Tax % | 200.00% | -26.67% | 13.33% | 40.00% | 40.00% | -13.79% | 50.00% | 12.50% | 14.29% | 11.11% | 13.11% | 8.33% | |
| Net Profit | -0.04 | 0.19 | 0.13 | 0.04 | 0.03 | 0.34 | 0.08 | 0.14 | 0.06 | 0.25 | 0.52 | 0.44 | 0.56 |
| EPS in Rs | 0.36 | 0.62 | 0.27 | 1.11 | 2.31 | 1.96 | 2.48 | ||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 575.00% | -31.58% | -69.23% | -25.00% | 1033.33% | -76.47% | 75.00% | -57.14% | 316.67% | 108.00% | -15.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -606.58% | -37.65% | 44.23% | 1058.33% | -1109.80% | 151.47% | -132.14% | 373.81% | -208.67% | -123.38% |
Continental Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -7% |
| 3 Years: | -23% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 41% |
| 3 Years: | 94% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | -9% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:01 pm
Balance Sheet
Last Updated: December 4, 2025, 2:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
| Reserves | 0.12 | 0.31 | 0.45 | 0.50 | 0.54 | 0.88 | 1.33 | 1.49 | 1.56 | 1.82 | 2.34 | 2.78 | 3.04 |
| Borrowings | 0.03 | 0.20 | 0.17 | 0.14 | 0.14 | 0.14 | 0.27 | 0.21 | 0.15 | 0.15 | 0.03 | 0.03 | 0.03 |
| Other Liabilities | 1.15 | 1.12 | 0.98 | 1.02 | 1.10 | 0.87 | 0.84 | 0.91 | 0.96 | 0.86 | 0.95 | 0.98 | 1.02 |
| Total Liabilities | 2.29 | 2.63 | 2.60 | 2.66 | 2.78 | 2.89 | 4.69 | 4.86 | 4.92 | 5.08 | 5.57 | 6.04 | 6.34 |
| Fixed Assets | 1.90 | 2.05 | 1.98 | 1.91 | 1.86 | 1.80 | 1.95 | 1.86 | 1.78 | 1.70 | 2.49 | 2.59 | 2.63 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.39 | 0.58 | 0.62 | 0.75 | 0.92 | 1.09 | 2.74 | 3.00 | 3.14 | 3.38 | 3.08 | 3.45 | 3.71 |
| Total Assets | 2.29 | 2.63 | 2.60 | 2.66 | 2.78 | 2.89 | 4.69 | 4.86 | 4.92 | 5.08 | 5.57 | 6.04 | 6.34 |
Below is a detailed analysis of the balance sheet data for Continental Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 2.25 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.25 Cr..
- For Reserves, as of Sep 2025, the value is 3.04 Cr.. The value appears strong and on an upward trend. It has increased from 2.78 Cr. (Mar 2025) to 3.04 Cr., marking an increase of 0.26 Cr..
- For Borrowings, as of Sep 2025, the value is 0.03 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.03 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.98 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.04 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6.34 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.04 Cr. (Mar 2025) to 6.34 Cr., marking an increase of 0.30 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.63 Cr.. The value appears strong and on an upward trend. It has increased from 2.59 Cr. (Mar 2025) to 2.63 Cr., marking an increase of 0.04 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 3.71 Cr.. The value appears strong and on an upward trend. It has increased from 3.45 Cr. (Mar 2025) to 3.71 Cr., marking an increase of 0.26 Cr..
- For Total Assets, as of Sep 2025, the value is 6.34 Cr.. The value appears strong and on an upward trend. It has increased from 6.04 Cr. (Mar 2025) to 6.34 Cr., marking an increase of 0.30 Cr..
Notably, the Reserves (3.04 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.52 | -0.38 | -0.40 | -0.40 | -0.39 | -0.88 | -0.85 | -0.69 | -0.51 | -0.59 | -0.46 | -0.79 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 35.90 | 0.00 | 58.87 | 76.84 | 15.21 | 0.00 | 0.00 | 0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 35.90 | 0.00 | 58.87 | 76.84 | 15.21 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -591.55 | -891.28 | -707.65 | -517.08 | -586.39 | -1,248.68 | -741.77 | -1,440.79 | -539.90 | -555.80 | -677.86 | -1,260.91 |
| ROCE % | 2.62% | 15.85% | 10.22% | 3.68% | 3.61% | 16.76% | 7.16% | 5.13% | 2.78% | 7.33% | 14.71% | 10.74% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.94 | 2.30 | 1.11 | 0.27 | 0.64 |
| Diluted EPS (Rs.) | 1.94 | 2.30 | 1.11 | 0.27 | 0.64 |
| Cash EPS (Rs.) | 2.26 | 2.62 | 1.50 | 0.66 | 1.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.37 | 20.42 | 18.11 | 16.93 | 16.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.37 | 20.42 | 18.11 | 16.93 | 16.64 |
| Revenue From Operations / Share (Rs.) | 0.98 | 1.88 | 1.95 | 2.13 | 0.86 |
| PBDIT / Share (Rs.) | 2.63 | 3.17 | 1.76 | 0.87 | 1.30 |
| PBIT / Share (Rs.) | 2.31 | 2.85 | 1.37 | 0.47 | 0.91 |
| PBT / Share (Rs.) | 2.14 | 2.69 | 1.22 | 0.31 | 0.73 |
| Net Profit / Share (Rs.) | 1.94 | 2.30 | 1.11 | 0.26 | 0.63 |
| PBDIT Margin (%) | 266.38 | 168.23 | 90.44 | 41.04 | 150.95 |
| PBIT Margin (%) | 233.75 | 151.43 | 70.23 | 22.34 | 106.24 |
| PBT Margin (%) | 216.58 | 142.87 | 62.66 | 14.72 | 85.45 |
| Net Profit Margin (%) | 195.95 | 122.27 | 56.84 | 12.51 | 73.82 |
| Return on Networth / Equity (%) | 8.66 | 11.28 | 6.12 | 1.57 | 3.83 |
| Return on Capital Employeed (%) | 10.11 | 13.65 | 7.17 | 2.65 | 5.19 |
| Return On Assets (%) | 7.21 | 9.30 | 4.91 | 1.21 | 2.95 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
| Asset Turnover Ratio (%) | 0.03 | 0.07 | 0.08 | 0.09 | 0.04 |
| Current Ratio (X) | 3.47 | 3.14 | 3.26 | 2.62 | 2.47 |
| Quick Ratio (X) | 3.47 | 3.14 | 3.26 | 2.62 | 2.47 |
| Interest Coverage Ratio (X) | 15.52 | 19.64 | 11.95 | 5.38 | 7.26 |
| Interest Coverage Ratio (Post Tax) (X) | 12.41 | 15.28 | 8.51 | 2.64 | 4.55 |
| Enterprise Value (Cr.) | 13.92 | 14.23 | 14.99 | 26.92 | 1.07 |
| EV / Net Operating Revenue (X) | 62.57 | 33.58 | 34.17 | 56.21 | 5.50 |
| EV / EBITDA (X) | 23.49 | 19.96 | 37.78 | 136.97 | 3.65 |
| MarketCap / Net Operating Revenue (X) | 75.81 | 39.80 | 39.39 | 60.41 | 15.40 |
| Price / BV (X) | 3.35 | 3.67 | 4.24 | 7.60 | 0.79 |
| Price / Net Operating Revenue (X) | 75.83 | 39.80 | 39.41 | 60.43 | 15.41 |
| EarningsYield | 0.02 | 0.03 | 0.01 | 0.00 | 0.04 |
After reviewing the key financial ratios for Continental Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has decreased from 2.30 (Mar 24) to 1.94, marking a decrease of 0.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has decreased from 2.30 (Mar 24) to 1.94, marking a decrease of 0.36.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has decreased from 2.62 (Mar 24) to 2.26, marking a decrease of 0.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.37. It has increased from 20.42 (Mar 24) to 22.37, marking an increase of 1.95.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.37. It has increased from 20.42 (Mar 24) to 22.37, marking an increase of 1.95.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.98. It has decreased from 1.88 (Mar 24) to 0.98, marking a decrease of 0.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 3.17 (Mar 24) to 2.63, marking a decrease of 0.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.31. This value is within the healthy range. It has decreased from 2.85 (Mar 24) to 2.31, marking a decrease of 0.54.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 2.14, marking a decrease of 0.55.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 2. It has decreased from 2.30 (Mar 24) to 1.94, marking a decrease of 0.36.
- For PBDIT Margin (%), as of Mar 25, the value is 266.38. This value is within the healthy range. It has increased from 168.23 (Mar 24) to 266.38, marking an increase of 98.15.
- For PBIT Margin (%), as of Mar 25, the value is 233.75. This value exceeds the healthy maximum of 20. It has increased from 151.43 (Mar 24) to 233.75, marking an increase of 82.32.
- For PBT Margin (%), as of Mar 25, the value is 216.58. This value is within the healthy range. It has increased from 142.87 (Mar 24) to 216.58, marking an increase of 73.71.
- For Net Profit Margin (%), as of Mar 25, the value is 195.95. This value exceeds the healthy maximum of 10. It has increased from 122.27 (Mar 24) to 195.95, marking an increase of 73.68.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.66. This value is below the healthy minimum of 15. It has decreased from 11.28 (Mar 24) to 8.66, marking a decrease of 2.62.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.11. This value is within the healthy range. It has decreased from 13.65 (Mar 24) to 10.11, marking a decrease of 3.54.
- For Return On Assets (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 9.30 (Mar 24) to 7.21, marking a decrease of 2.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.03. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 3. It has increased from 3.14 (Mar 24) to 3.47, marking an increase of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 2. It has increased from 3.14 (Mar 24) to 3.47, marking an increase of 0.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 15.52. This value is within the healthy range. It has decreased from 19.64 (Mar 24) to 15.52, marking a decrease of 4.12.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 15.28 (Mar 24) to 12.41, marking a decrease of 2.87.
- For Enterprise Value (Cr.), as of Mar 25, the value is 13.92. It has decreased from 14.23 (Mar 24) to 13.92, marking a decrease of 0.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 62.57. This value exceeds the healthy maximum of 3. It has increased from 33.58 (Mar 24) to 62.57, marking an increase of 28.99.
- For EV / EBITDA (X), as of Mar 25, the value is 23.49. This value exceeds the healthy maximum of 15. It has increased from 19.96 (Mar 24) to 23.49, marking an increase of 3.53.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 75.81. This value exceeds the healthy maximum of 3. It has increased from 39.80 (Mar 24) to 75.81, marking an increase of 36.01.
- For Price / BV (X), as of Mar 25, the value is 3.35. This value exceeds the healthy maximum of 3. It has decreased from 3.67 (Mar 24) to 3.35, marking a decrease of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 75.83. This value exceeds the healthy maximum of 3. It has increased from 39.80 (Mar 24) to 75.83, marking an increase of 36.03.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Chemicals Ltd:
- Net Profit Margin: 195.95%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.11% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.66% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.47
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.1 (Industry average Stock P/E: 79.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 195.95%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | A-7, Sector-7, Noida, Gautam Budh Nagar Dist. Uttar Pradesh 201301 | info@continentalsoft.com www.continentalchemicalsltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Naresh Kumar Chibba | Managing Director |
| Ms. Sunaina Chibba | Director |
| Mr. Aditya Vikram Chibba | Director |
| Mr. Raghav Nathani | Independent Director |
| Mr. Gaurav Sachdeva | Independent Director |
FAQ
What is the intrinsic value of Continental Chemicals Ltd?
Continental Chemicals Ltd's intrinsic value (as of 22 January 2026) is ₹82.29 which is 4.16% higher the current market price of ₹79.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹17.8 Cr. market cap, FY2025-2026 high/low of ₹94.0/63.0, reserves of ₹3.04 Cr, and liabilities of ₹6.34 Cr.
What is the Market Cap of Continental Chemicals Ltd?
The Market Cap of Continental Chemicals Ltd is 17.8 Cr..
What is the current Stock Price of Continental Chemicals Ltd as on 22 January 2026?
The current stock price of Continental Chemicals Ltd as on 22 January 2026 is ₹79.0.
What is the High / Low of Continental Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Continental Chemicals Ltd stocks is ₹94.0/63.0.
What is the Stock P/E of Continental Chemicals Ltd?
The Stock P/E of Continental Chemicals Ltd is 30.1.
What is the Book Value of Continental Chemicals Ltd?
The Book Value of Continental Chemicals Ltd is 23.5.
What is the Dividend Yield of Continental Chemicals Ltd?
The Dividend Yield of Continental Chemicals Ltd is 0.00 %.
What is the ROCE of Continental Chemicals Ltd?
The ROCE of Continental Chemicals Ltd is 10.7 %.
What is the ROE of Continental Chemicals Ltd?
The ROE of Continental Chemicals Ltd is 9.15 %.
What is the Face Value of Continental Chemicals Ltd?
The Face Value of Continental Chemicals Ltd is 10.0.